Risk stratification determines the protocol of management used for<unk>  patients. Radiotherapy is the mainstay of treatment for<unk> . Radiotherapy for<unk>  must be started within the 6 weeks period following surgery. Adjunctive chemotherapy is also required for the management of certain<unk>  patients. Recommended chemotherapeutic regimens used for the management of standard risk<unk>  patients include a combination of lomustine, vincristine, and cisplatin.
Medulloblastoma medical therapy
Mixed gliomas medical therapy
Neurofibroma medical therapy
Medulloblastoma surgery
Glioblastoma multiforme surgery
Schwannoma surgery
Ependymoma surgery
Glioma medical therapy